These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 25363560)
1. Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells. Nieda M; Terunuma H; Eiraku Y; Deng X; Nicol AJ Exp Dermatol; 2015 Jan; 24(1):35-41. PubMed ID: 25363560 [TBL] [Abstract][Full Text] [Related]
2. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810 [TBL] [Abstract][Full Text] [Related]
3. Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation. Takahara M; Miyai M; Tomiyama M; Mutou M; Nicol AJ; Nieda M J Leukoc Biol; 2008 Mar; 83(3):742-54. PubMed ID: 18156189 [TBL] [Abstract][Full Text] [Related]
4. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Jayaprabhu S; Pecorelli S; Parham GP; Cannon MJ Clin Cancer Res; 2001 Mar; 7(3 Suppl):804s-810s. PubMed ID: 11300476 [TBL] [Abstract][Full Text] [Related]
5. Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors. Di Pucchio T; Pilla L; Capone I; Ferrantini M; Montefiore E; Urbani F; Patuzzo R; Pennacchioli E; Santinami M; Cova A; Sovena G; Arienti F; Lombardo C; Lombardi A; Caporaso P; D'Atri S; Marchetti P; Bonmassar E; Parmiani G; Belardelli F; Rivoltini L Cancer Res; 2006 May; 66(9):4943-51. PubMed ID: 16651452 [TBL] [Abstract][Full Text] [Related]
11. Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro. Koya RC; Weber JS; Kasahara N; Lau R; Villacres MC; Levine AM; Stripecke R Hum Gene Ther; 2004 Aug; 15(8):733-48. PubMed ID: 15319031 [TBL] [Abstract][Full Text] [Related]
12. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia]. Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells. Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414 [TBL] [Abstract][Full Text] [Related]
14. Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes. Pfeiffer IA; Zinser E; Strasser E; Stein MF; Dörrie J; Schaft N; Steinkasserer A; Knippertz I Immunobiology; 2013 Nov; 218(11):1392-401. PubMed ID: 23932569 [TBL] [Abstract][Full Text] [Related]
15. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814 [TBL] [Abstract][Full Text] [Related]
16. [Roles of interleukin-10 differentiated dendritic cell of allergic asthma patients in T-lymphocyte proliferation in vitro]. Tang JF; Guan SH; Wang ZG Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2851-4. PubMed ID: 23290216 [TBL] [Abstract][Full Text] [Related]
17. Interferon-beta induces the development of type 2 dendritic cells. Huang YM; Hussien Y; Yarilin D; Xiao BG; Liu YJ; Link H Cytokine; 2001 Mar; 13(5):264-71. PubMed ID: 11243704 [TBL] [Abstract][Full Text] [Related]
18. Generation of mature dendritic cells with unique phenotype and function by in vitro short-term culture of human monocytes in the presence of interleukin-4 and interferon-beta. Zhang LF; Okuma K; Tanaka R; Kodama A; Kondo K; Ansari AA; Tanaka Y Exp Biol Med (Maywood); 2008 Jun; 233(6):721-31. PubMed ID: 18408138 [TBL] [Abstract][Full Text] [Related]
20. Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation. Wang YS; Chi KH; Liao KW; Liu CC; Cheng CL; Lin YC; Cheng CH; Chu RM Can J Vet Res; 2007 Jul; 71(3):165-74. PubMed ID: 17695590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]